CCN3 peptides and analogs thereof for therapeutic use
US8518395B2 · kind B2 · utility
3Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 4, 2011 |
| Grant date | Aug 27, 2013 |
| Priority date | — |
| Expiry date | Apr 4, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/475
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a CCN3 peptide for treating a subject in need thereof having an amino acid sequence identified as CCNp37, CCNp38 (human), CCNp38 (mouse), a cysteine-substituted CCNp37, cysteine-substituted CCNp38 (human) or a cysteine-substituted CCNp38 (mouse).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.